Image – Interventional flashlight

DOI: 10.4244/EIJ-D-18-01212

Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension

Lorenz Räber1, MD; Yasushi Ueki1, MD; Irene M. Lang2, MD

Figure 1. Imaging of left A10 before and after balloon angioplasty. Panels A-C illustrate angiograms. Panels D and E show OCT images in the planes highlighted in panels A and C.

A 65-year-old dyspnoeic male was diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH) and a mean pulmonary arterial pressure of 45 mmHg, cardiac index of 2.4 L/min/m2, and pulmonary vascular resistance of 560 dyn·s·cm–5. The interdisciplinary PH board classified the patient’s CTEPH as technically operable with a poor risk-benefit ratio. An alternative mechanical treatment is balloon pulmonary angioplasty (BPA), a recently refined percutaneous technique that is emerging in Europe1. Figure 1A shows direct injection of left A10 during the patient`s first BPA session, depicting a focal bifurcational lesion. Optical coherence tomography showed a typical chanelled organised thrombus (Figure 1D, Moving image 1). After a single 8 atm inflation of a 4/20 mm MAVERICK™ balloon (Boston Scientific, Marlborough, MA, USA) (Figure 1B), angiography demonstrated adequate expansion of the lesion (Figure 1C). OCT immediately after balloon angioplasty (Figure 1E, Moving image 2) documented eccentric compression of obstructive material, without medial dissection (Figure 1D, arrows flanking the OCT catheter point to the structures displaced between Figure 1D and Figure 1E). “Breaking webs without dissection of the media” is the principle of BPA, and distinguishes this technique from coronary balloon angioplasty. Sparing the media is an interventional goal that is not always met, but may be achieved by using undersized balloons2. The fact that CTEPH is a disease of the lumen rather than a disease of the vessel wall itself may be a further reason for the lack of restenosis after BPA. This case illustrates the mechanical concept of BPA breaking and displacing intravascular webs, thus restoring normal flow and vessel function.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Volume 15 Number 9
Oct 4, 2019
Volume 15 Number 9
View full issue


Key metrics

On the same subject

10.4244/EIJV12SXA8 May 16, 2016
Percutaneous treatment of chronic thromboembolic pulmonary hypertension (CTEPH)
Muller DW and Liebetrau C
free

Clinical Research

10.4244/EIJ-D-21-00230 Jan 28, 2022
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry
Darocha S et al
free
Trending articles
243.1

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
188.65

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
169.3

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved